You are here: Industry Insights > immunotherapy

News List

Greenwich Lifesciences Completes Manufacturing of GP2 contractpharma
October 15, 2020
The active ingredient is ready for its planned Phase III clinical trial.
UK bladder cancer patients get early access to Bavencio pharmatimes
September 04, 2020
Merck and Pfizer’s Bavencio (avelumab) is now available under the UK's Early Access to Medicines Scheme (EAMS) giving some patients with bladder cancer the chance to receive treatment with the immunotherapy before its approval in Europe.
NICE green light for immunotherapy Bavencio pharmatimes
September 03, 2020
The National Institute for Health and Care Excellence (NICE) has now published final guidelines endorsing NHS use of Merck and Pfizer's immunotherapy Bavencio (avelumab) in combination with axitinib as a first-line treatment for kidney cancer.
GEMoaB, Intellia Enter Cellular Immunotherapy Research Pact contractpharma
July 21, 2020
Will combine GEMoaB's RevCAR technology platform with Intellia's genome editing technologies to discover and develop allogeneic cellular immunotherapies.
Sintilimab Expected to Break the “Iron Triangle” to Become the Fourth Major Immunotherapy for Esophagus Cancer in China PharmaSources/Yefenghong
July 06, 2020
A clinical trial has been conducted to use the Chinese-produced sintilimab as a second-line therapy for advanced ESCC and has achieved positive results.
BioInvent, Pfizer Extend Immunotherapy Research Term contractpharma
July 02, 2020
Allows the companies to further identify and characterize new targets and antibodies leveraging BioInvent's F.I.R.S.T drug discovery platform.
Cancer CART therapy: What are the benefits and stakes? expresspharma
June 15, 2020
Debamita Chatterjee, Ex-researcher, Harvard Medical School and NYAS/MIT/European Commission Innovation Mentor elaborates how R&D, regulatory and commercial activities have globally bolstered the technological promise of Cancer CART therapy and ...
Scientists identify targets for COVID-19 vaccine using cancer immunotherapy tools worldpharmanews
June 10, 2020
Cancer researchers at Children's Hospital of Philadelphia (CHOP) have harnessed tools used for the development of cancer immunotherapies and adapted them to identify regions of the SARS-CoV-2 virus to target with a vaccine...
Study reveals immunotherapy after chemotherapy slows metastatic bladder cancer expresspharma
April 13, 2020
The randomised Phase 2 trial tested immunotherapy known as pembrolizumab in 108 patients after they were treated with platinum-based chemotherapy.
Coronavirus Consortium Accelerates Immunotherapy Research contractpharma
April 01, 2020
To leverage Carterra’s LSA platform to screen hundreds of antibodies in a few days as CoVIC seeks to find therapeutic candidates for COVID-19 in just weeks.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 Next page